[HTML][HTML] MicroRNA as potential biomarkers of platelet function on antiplatelet therapy: a review
P Czajka, A Fitas, D Jakubik, C Eyileten… - Frontiers in …, 2021 - frontiersin.org
MicroRNAs (miRNAs) are small, non-coding RNAs, able to regulate cellular functions by
specific gene modifications. Platelets are the major source for circulating miRNAs, with …
specific gene modifications. Platelets are the major source for circulating miRNAs, with …
Lifestyle approach and medical therapy of lower extremity peripheral artery disease
Lower extremity peripheral artery disease (PAD) is common among patients with several risk
factors, such as elderly, smoking, hypertension, and diabetes mellitus (DM). Notably, PAD is …
factors, such as elderly, smoking, hypertension, and diabetes mellitus (DM). Notably, PAD is …
[HTML][HTML] Hydroxyurea ameliorates atherosclerosis in ApoE-/-mice by potentially modulating Niemann-Pick C1-like 1 protein through the gut microbiota
XY Yang, H Yu, J Fu, HH Guo, P Han, SR Ma… - Theranostics, 2022 - ncbi.nlm.nih.gov
Rationale: The efficacy and mechanism of hydroxyurea in the treatment of atherosclerosis
have rarely been reported. The goal of this study was to investigate the efficacy of …
have rarely been reported. The goal of this study was to investigate the efficacy of …
[HTML][HTML] Model based on single-nucleotide polymorphism to discriminate aspirin resistance patients
Q Liu, S Guo, N Wang, K Wang, S Mo, X Li… - Stroke and Vascular …, 2023 - svn.bmj.com
Background Aspirin is widely used for preventing ischaemic events. About 20%–40% of
patients have aspirin resistance (ASR), which prevents them from benefiting from aspirin …
patients have aspirin resistance (ASR), which prevents them from benefiting from aspirin …
[HTML][HTML] The association between aspirin use and immune-related adverse events in specific cancer patients receiving ICIs therapy: analysis of the FAERS database
H Yang, Z Liu, R Li, R Huang, X Peng - Frontiers in Pharmacology, 2023 - frontiersin.org
Background: The promise of immune checkpoint inhibitors (ICIs) therapy in cancer treatment
is tempered by the occurrence of immune-related adverse events (irAEs). Many patients …
is tempered by the occurrence of immune-related adverse events (irAEs). Many patients …
Epidemiology, pathophysiology, and management of coronary artery disease in the elderly
K Fadah, A Hechanova… - International Journal of …, 2022 - thieme-connect.com
Elderly patients over the age of≥ 75 years are especially susceptible to coronary artery
disease (CAD) as age is an important nonmodifiable risk factors for atherosclerosis and a …
disease (CAD) as age is an important nonmodifiable risk factors for atherosclerosis and a …
Aspirin relieves the calcification of aortic smooth muscle cells by enhancing the heat shock response
Q Shen, Q Chen, Y Liu, X Xue, X Shen, Q He… - Pharmaceutical …, 2022 - Taylor & Francis
Context Vascular calcification is a major complication of chronic renal failure, which has
been identified as an active process partly driven by osteogenic transition of vascular …
been identified as an active process partly driven by osteogenic transition of vascular …
[HTML][HTML] Prescription practices in patients with mild to moderate CKD in India
Introduction Patients with chronic kidney disease (CKD) require multiple medications. There
is no information on prescription patterns or the use of evidence-based therapies for …
is no information on prescription patterns or the use of evidence-based therapies for …
Efficacy and Safety of Cilostazol for Atherosclerosis: A Meta-analysis of Randomized Controlled Trials
H Wan, T Huang, P Yang, T Wu… - Journal of …, 2022 - journals.lww.com
To investigate the efficacy and safety of cilostazol for atherosclerosis. PubMed, Embase, and
the Cochrane Central Register of Controlled Trials from inception to May 29, 2021, were …
the Cochrane Central Register of Controlled Trials from inception to May 29, 2021, were …
Could low doses acetylsalicylic acid prevent thrombotic complications in COVID-19 patients?
F Cacciapuoti, F Cacciapuoti - Clinical and Applied …, 2021 - journals.sagepub.com
Severe Acute Respiratory Syndrome-Coronavirus-2 (SARS-CoV-2) can induce inflammatory
and thrombotic complications of pulmonary district (interstitial pneumonia), sometimes …
and thrombotic complications of pulmonary district (interstitial pneumonia), sometimes …